Condition
Duodenal Carcinoma
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 4 (1)
Trial Status
Suspended1
Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT05223036Phase 2Suspended
Testing Obeticholic Acid for Familial Adenomatous Polyposis
NCT07262957Phase 4Recruiting
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Showing all 2 trials